The Dry Eye Disease Market was valued at approximately USD 6.5 Billion in 2023 and is expected to grow at a strong CAGR of around 4% during the forecast period (2024-2032)

The Dry Eye Disease industry has been witnessing steady growth in North America over the past few years due to factors such as the increasing prevalence of dry eye disease, a growing geriatric population, increased acceptance of novel therapies, and a growing awareness of the concept of personalized medicine and the similar, North America and particularly the USA, is considered to be one of the most lucrative regions in the global Dry Eye Disease market. It expands the market covering a wide range of applications related to the improvement of dry eye disease. Here's a detailed overview:

Driving Factors for the Market in North America:

One major factor propelling the Dry Eye Disease market in North America is the rising incidence of this condition and increasing geriatric population. For instance, as per the data of America Academy of Ophthalmology, approximately 20 million people in the United States are currently living with dry eye disease (DED), and that number is growing in both young and old adults. Further, about 250 million people are living with dry eye disease. Further, the aging population is a significant driving factor for the dry eye disease market in North America. As the population ages, the prevalence of dry eye disease increases. According to the U.S. Census Bureau, the number of Americans aged 65 and older is projected to reach 94.7 million by 2060, up from 54.1 million in 2019. Aging leads to physiological changes in tear production and quality, making older adults more susceptible to dry eye disease.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/dry-eye-disease-market?popup=report-enquiry

In recent years, there has been a notable increase in the incidence and prevalence of dry eye disease across North America. This trend is attributed to several factors:

Autoimmune Disorders

Sjogren’s syndrome and rheumatoid arthritis are examples of autoimmune diseases with increased association with dry eye disease. Self-reported Sjögren’s syndrome sufferers indicate a population of approximately four million Americans; dry eye is a common symptom listed by the Sjögren’s Syndrome Foundation.

Post-Menopausal Changes

This study has shown that hormonal fluctuations which are characteristic of post-menopausal women play a major role in the development of dry eye disease. The report also introduces that estrogen and androgen influence the quality and quantity of tear secretion. According to the North American Menopause Society on the prevalence of dry eye, 40% of women having undergone menopause are likely to have dry eye symptoms.

Contact Lens Use

Another cause towards development of dry eye disease is through the consistent use of contact lenses. Cosmetic lenses harm the tear film and cause discomfort and dryness to the eyes. According to the CDC current data, approximately 45 million wear contact lenses, many of whom encounter dry eye consequences.

Click here to view the Report Description & TOC: https://univdatos.com/reports/dry-eye-disease-market

The expanding therapeutic landscape of dry eye disease signifies a growing recognition of the condition's complexity and the need for diverse treatment options. With advancements in understanding the pathophysiology of DED, the market is seeing an influx of novel therapies aimed at providing more effective and tailored treatments.

Conclusion:

In conclusion, the Dry Eye Disease market in North America is witnessing substantial growth, fueled by an aging population, increased incidence of dry eye conditions, and the adoption of innovative treatments. The rising prevalence of autoimmune disorders, hormonal changes post-menopause, and prolonged contact lens use further contribute to the market's expansion. With approximately 20 million Americans affected and the number expected to grow, the demand for effective and diverse treatment options is paramount. Advancements in understanding DED's pathophysiology are driving the development of novel therapies, positioning North America, particularly the U.S., as a leading market for Dry Eye Disease solutions. According to the UnivDatos the surge in the incidence of dry eye disease cases and the rise in demand for personalized medicine will drive the global scenario of Dry Eye Disease.

Contact Us:

UnivDatos

Email: contact@univdatos.com 

Contact no: +1 978 7330253

Website: www.univdatos.com

Linked In: https://www.linkedin.com/company/univ-datos/